ACORN BIOVENTURES, L.P. enters ONKURE THERAPEUTICS, INC. with 1.44M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/9/2024ACC: 0000950170-24-113744
10% Owner
Since Oct 2024
1.44M
Baseline shares
100% direct
1.44M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Class A Common Stock
DirectShares owned1.44M
Total
1.44M direct1.44M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 1.44M | Direct |
| Total | 1.44M | 1.44M direct |
Derivative Holdings0
No derivative holdings reported